US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

104.33

-0.2100-0.20%

Post-market: 104.330.00000.00%17:54 EDT

Volume:6.72M

Turnover:699.21M

Market Cap:130.06B

PE:274.55

High:105.23

Open:104.10

Low:103.09

Close:104.54

Loading ...

Overview Company News Filings

Gilead reports ASCENT-04/KEYNOTE-D19 study met primary endpoint

Gilead ASCENT-04 data a ‘welcome surprise,’ says Oppenheimer

Gilead Says Trodelvy-Keytruda Combination Improved Progression-Free Survival in Breast Cancer Study

MT Newswires Live

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type

BRIEF-Gilead Reports Positive Topline Results From Phase 3 Ascent-04/Keynote-D19 Study

Gilead: Positive Topline Results From Phase 3 Ascent-04/Keynote-D19 Study

THOMSON REUTERS

Gilead: Overall Survival (Os), Key Secondary Endpoint, Wasn't Mature at Time of Pfs Primary Analysis

THOMSON REUTERS

Gilead: Study Showed Superiority of Trodelvy Plus Keytruda VS Standard of Care (Soc) in 1L Metastatic Triple-Negative Breast Cancer (Mtnbc)

THOMSON REUTERS

Gilead: Study Met Main Goal, With Statistically Significant,Clinically Meaningful Improvement in Pfs

THOMSON REUTERS

Gilead: Will Continue to Monitor Os Outcomes

THOMSON REUTERS

Gilead: Trodelvy Plus Keytruda Shows Early Trend in Improvement for Os VS Soc in Patients With Previously Untreated Pd-L1+ (CPS ≥10) Mtnbc

THOMSON REUTERS

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated Pd-L1+ Metastatic Triple-Negative Breast Cancer

THOMSON REUTERS

Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer

Gilead Sciences: Strong Financial Outlook and Strategic Positioning Justify Buy Rating

Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?

Leerink Partners Adjusts Price Target on Gilead Sciences to $105 From $104, Keeps Outperform Rating

MT Newswires Live

Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings Growth

Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell

MT Newswires Live

BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GILD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"Gilead Sciences","latestPrice":104.33,"timestamp":1745265600000,"preClose":104.54,"halted":0,"volume":6719153,"hourTrading":{"tag":"盘后","latestPrice":104.33,"preClose":104.33,"latestTime":"17:54 EDT","volume":260649,"amount":27195415.51419,"timestamp":1745272497227},"delay":0,"floatShares":1243965050,"shares":1246634469,"eps":0.38,"marketStatus":"Post-Mkt","change":-0.21,"latestTime":"04-21 18:27:21 EDT","open":104.1,"high":105.225,"low":103.09,"amount":699212060.63709,"amplitude":0.020423,"askPrice":105.39,"askSize":1,"bidPrice":104.6,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.38,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":104.54,"dividendRate":0.029522,"preHourTrading":{"tag":"盘前","latestPrice":104.5,"preClose":104.54,"latestTime":"09:29 EDT","volume":1508,"amount":156914.7892,"timestamp":1745242199999},"postHourTrading":{"tag":"盘后","latestPrice":104.33,"preClose":104.33,"latestTime":"17:54 EDT","volume":260649,"amount":27195415.51419,"timestamp":1745272497227},"volumeRatio":0.889329,"impliedVol":0.4311,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1243965050,"roa":"11.03%","roe":"2.29%","lyrEps":0.384923,"volumeRatio":0.889329,"shares":1246634469,"dividePrice":3.08,"high":105.225,"amplitude":0.020423,"preClose":104.54,"low":103.09,"week52Low":62.07,"pbRate":"6.73","psRate":"4.52","week52High":119.96,"institutionHeld":0.7997,"latestPrice":104.33,"committee":0.666667,"eps":0.38,"divideRate":0.029522,"volume":6719153,"delay":0,"ttmEps":0.38,"open":104.1,"prevYearClose":92.37,"prevWeekClose":104.54,"prevMonthClose":112.05,"prevQuarterClose":112.05,"fiveDayClose":103.63,"twentyDayClose":107.08,"sixtyDayClose":92.92,"earningDate":1745424000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529800286","title":"Gilead reports ASCENT-04/KEYNOTE-D19 study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2529800286","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529800286?lang=en_us&edition=fundamental","pubTime":"2025-04-21 22:15","pubTimestamp":1745244937,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) announced topline results from the Phase 3 ASCENT-04/KEYNOTE-D19 study, demonstrating that Trodelvy plus Keytruda significan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-reports-ascent-04-keynote-d19-study-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-reports-ascent-04-keynote-d19-study-met-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0266013472.USD","LU0965509101.SGD","LU1917777945.USD","LU1035773651.USD","GILD","LU1116320901.HKD","LU0265550359.USD","BK4534","SG9999001176.USD","SG9999002232.USD","LU1941712348.USD","SG9999002224.SGD","LU0965509283.SGD","LU1983299246.USD","SG9999014575.USD","LU1023059063.AUD","LU1571399168.USD","BK4516","IE0002141913.USD","LU1116320737.USD","LU1585245621.USD","LU1989772840.SGD","LU1061106388.HKD","LU1093756325.SGD","SG9999001440.SGD","BK4568","LU0006306889.USD","BK4583","IE00B1BXHZ80.USD","LU0234572021.USD","LU1066051811.HKD","IE00BLSP4239.USD","LU0058720904.USD","LU2112291526.USD","LU1066051225.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU2468319806.SGD","LU0109394709.USD","LU1934455277.USD","LU1941712264.USD","BK4585","BK4550","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","MRK","LU0861579265.USD","LU0289739699.SGD","LU2361044865.SGD","BK4578"],"gpt_icon":0},{"id":"2529800281","title":"Gilead ASCENT-04 data a ‘welcome surprise,’ says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529800281","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529800281?lang=en_us&edition=fundamental","pubTime":"2025-04-21 22:15","pubTimestamp":1745244927,"startTime":"0","endTime":"0","summary":"Oppenheimer says Gilead (GILD) provided a “welcome surprise” this morning with ASCENT-04 hitting its primary endpoint. The firm was not expecting t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-ascent-04-data-a-welcome-surprise-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-ascent-04-data-a-welcome-surprise-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","GILD","BK4568","LU1066053197.SGD","LU1585245621.USD","IE00B19Z3581.USD","LU2468319806.SGD","LU0058720904.USD","IE00BKVL7J92.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4139","IE00B3T34201.USD","LU0109394709.USD","BK4583","LU1066051498.USD","OPY","LU2087621335.USD","BK4532","BK4550","IE0002270589.USD","BK4588","LU0289739699.SGD","BK4566","BK4578","LU2089984988.USD","BK4585","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4127","LU1839511570.USD"],"gpt_icon":0},{"id":"2529804157","title":"Gilead Says Trodelvy-Keytruda Combination Improved Progression-Free Survival in Breast Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529804157","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529804157?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:37","pubTimestamp":1745242672,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Monday that a phase 3 breast cancer study met its primary endpoint, showing that Trodelvy plus Keytruda \"significantly\" improved progression-free survival compared with Keytruda and chemotherapy.The safety profile of the Trodelvy-Keytruda combination also showed consistency with the know safety profile of each agent, Gilead said.The company said overall survival is a key secondary endpoint and was not mature during the progression-free survival analysis, but there was an early trend in improved overall survival with the combination.Merck  and Gilead entered into a collaboration in 2021 to evaluate the Trodelvy-Keytruda combination compared to Keytruda plus chemotherapy in patients with previously untreated, inoperable locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1, Gilead said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1941712348.USD","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0965509101.SGD","LU2023250843.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","GILD","LU1066051225.USD","IE00B2B36J28.USD","LU1699723380.USD","SG9999001176.USD","LU2324357040.USD","BK4588","IE00BLSP4452.SGD","BK4566","LU2023250504.SGD","BK4516","LU1116320737.USD","LU0109394709.USD","LU0320765992.SGD","LU0320765489.SGD","BK4550","BK4568","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1929549753.HKD","LU0122379950.USD","SG9999014567.USD","LU1037948541.HKD","LU2106854487.HKD","LU0320765646.SGD","MRK","LU0203345920.USD","LU0889565916.HKD","LU1057294990.SGD","SG9999001440.SGD","LU0861579265.USD","LU0106261372.USD","LU1983299246.USD","SG9999015358.SGD","LU0965509283.SGD","SGXZ57979304.SGD","IE0002270589.USD","LU1571399168.USD","SG9999002224.SGD","SG9999013999.USD","LU1934455194.USD","LU0985320562.USD"],"gpt_icon":0},{"id":"2529000618","title":"Why Investors Need to Take Advantage of These 2 Medical Stocks Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2529000618","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529000618?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:00","pubTimestamp":1745240408,"startTime":"0","endTime":"0","summary":"Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the metrics and results to consider, earnings is one of the most important.We know earnings results are vital, but how a company performs compared to bottom line expectations can be even more important when it comes to stock prices, especially in the near-term. This means that investors might want to take advantage of these earnings surprises.The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to look at a qualifying stock. CVS Health  holds a Zacks Rank #3 at the moment and its Most Accurate Estimate comes in at $1.68 a share 10 days away from its upcoming earnings release on May 1, 2025.CVS is one of just a large database of Medical stocks with positive ESPs. Another solid-looking stock is Gilead Sciences .This article originally publishe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-investors-advantage-2-medical-130008567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU0061475181.USD","BK4581","GILD","LU0072461881.USD","BK4568","LU1066053197.SGD","LU0162691827.USD","LU1585245621.USD","ISBC","IE00B19Z3581.USD","LU0211331839.USD","LU2468319806.SGD","LU0058720904.USD","IE00BKVL7J92.USD","LU1571399168.USD","LU1699723380.USD","IE00B19Z3B42.SGD","BK4196","LU0320765992.SGD","BK4504","BK4139","IE00B3T34201.USD","LU0109394709.USD","BK4583","LU0006061336.USD","LU0070302665.USD","LU1066051498.USD","BK4211","LU2087621335.USD","BK4532","CVS","BK4550","LU0208291251.USD","IE0002270589.USD","LU1059921491.USD","BK4588","LU0289739699.SGD","BK4566","LU0320765489.SGD","BK4578","LU2089984988.USD","BK4585","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1839511570.USD"],"gpt_icon":0},{"id":"2529280510","title":"Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type","url":"https://stock-news.laohu8.com/highlight/detail?id=2529280510","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529280510?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:31","pubTimestamp":1745238686,"startTime":"0","endTime":"0","summary":"Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer typeBy Deena BeasleyApril 21 (Reuters) - Gilead Sciences GILD.O said on Monday a late-stage study showed that its drug Trodel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nL1N3QY02V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU2106854487.HKD","LU1839511570.USD","LU1929549753.HKD","LU0208291251.USD","IE00B1BXHZ80.USD","SG9999001176.SGD","SG9999002224.SGD","SG9999014559.SGD","LU0234572021.USD","GILD","SG9999015341.SGD","LU0265550946.USD","IE00B2B36J28.USD","BK4559","IE00B19Z3B42.SGD","LU1037948897.HKD","LU1035773651.USD","IE00B7SZLL34.SGD","LU1116320737.USD","BK4550","LU2324357040.USD","SGXZ57979304.SGD","LU0058720904.USD","LU0985320562.USD","LU0203345920.USD","IE000M9KFDE8.USD","LU1941712264.USD","MRK","LU2361044949.HKD","IE00BLSP4239.USD","LU1989771016.USD","LU2468319806.SGD","LU1093756325.SGD","LU0265550359.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","BK4588","SG9999001440.SGD","LU0266013472.USD","LU0965509101.SGD","SG9999014567.USD","IE00B4R5TH58.HKD","LU2023250843.SGD","LU1066051225.USD","LU1093756168.USD","LU0238689110.USD","LU0861579265.USD","LU0006306889.USD","LU0965509283.SGD"],"gpt_icon":0},{"id":"2529806872","title":"BRIEF-Gilead Reports Positive Topline Results From Phase 3 Ascent-04/Keynote-D19 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529806872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529806872?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238609,"startTime":"0","endTime":"0","summary":"BRIEF-Gilead Reports Positive Topline Results From Phase 3 Ascent-04/Keynote-D19 StudyApril 21  - Gilead Sciences Inc GILD.O:TRODELVY PLUS KEYTRUDA DEMONSTRATES A STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL IMPROVEMENT IN PROGRESSION FREE SURVIVAL IN PATIENTS WITH PREVIOUSLY UNTREATED PD-L1+ METASTATIC TRIPLE-NEGATIVE BREAST CANCERGILEAD: POSITIVE TOPLINE RESULTS FROM PHASE 3 ASCENT-04/KEYNOTE-D19 STUDYGILEAD: STUDY SHOWED SUPERIORITY OF TRODELVY PLUS KEYTRUDA VERSUS STANDARD OF CARE  IN 1L METASTATIC TRIPLE-NEGATIVE BREAST CANCER GILEAD: STUDY MET MAIN GOAL, WITH STATISTICALLY SIGNIFICANT,CLINICALLY MEANINGFUL IMPROVEMENT IN PFSGILEAD: OVERALL SURVIVAL , KEY SECONDARY ENDPOINT, WASN'T MATURE AT TIME OF PFS PRIMARY ANALYSISGILEAD: TRODELVY PLUS KEYTRUDA SHOWS EARLY TREND IN IMPROVEMENT FOR OS VERSUS SOC IN PATIENTS WITH PREVIOUSLY UNTREATED PD-L1+  MTNBCGILEAD: WILL CONTINUE TO MONITOR OS OUTCOMESFurther company coverage: GILD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","LU1989771016.USD","SG9999002224.SGD","LU1929549753.HKD","LU1989772840.SGD","LU0109394709.USD","LU0265550946.USD","LU0861579265.USD","LU0889565916.HKD","LU1037948897.HKD","LU1116320737.USD","MRK","BK4588","LU0058720904.USD","LU1057294990.SGD","LU1917777945.USD","BK4533","SG9999015358.SGD","LU2461242641.AUD","GILD","LU0965508806.USD","LU2468319806.SGD","LU0289739699.SGD","LU1934455194.USD","IE0002141913.USD","LU0320765489.SGD","IE0009355771.USD","LU1983299246.USD","LU0070302665.USD","BK4007","IE00B4R5TH58.HKD","BK4532","LU0320765992.SGD","LU1035773651.USD","SG9999001440.SGD","LU1291159041.SGD","BK4568","LU1066051225.USD","IE00BLSP4239.USD","IE00BN8TJ469.HKD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU0234570918.USD","LU1023059063.AUD","LU1934455277.USD","BK4516","IE00BSNM7G36.USD","LU0203345920.USD","BK4534","LU0965509283.SGD"],"gpt_icon":1},{"id":"2529805192","title":"Gilead: Positive Topline Results From Phase 3 Ascent-04/Keynote-D19 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529805192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529805192?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4585","LU0889565916.HKD","LU1839511570.USD","LU0320765992.SGD","GILD","LU0109394709.USD","BK4568","IE00B3T34201.USD","LU1430594728.SGD","LU1571399168.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0234570918.USD","BK4532","IE00BKVL7J92.USD","LU1066053197.SGD","LU2468319806.SGD","BK4578","IE00B19Z3B42.SGD","IE0002270589.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4550","LU2087621335.USD","LU2089984988.USD","BK4588","BK4139","LU1066051498.USD","LU1585245621.USD","BK4566"],"gpt_icon":0},{"id":"2529805167","title":"Gilead: Overall Survival (Os), Key Secondary Endpoint, Wasn't Mature at Time of Pfs Primary Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2529805167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529805167?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU2089984988.USD","BK4568","BK4139","LU1571399168.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","LU0109394709.USD","LU2087621335.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4588","BK4585","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","BK4583","BK4532","BK4550","BK4578"],"gpt_icon":0},{"id":"2529805118","title":"Gilead: Study Showed Superiority of Trodelvy Plus Keytruda VS Standard of Care (Soc) in 1L Metastatic Triple-Negative Breast Cancer (Mtnbc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529805118","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529805118?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","IE00B7SZLL34.SGD","LU1839511570.USD","LU1066051225.USD","LU0234572021.USD","LU2089984988.USD","IE00B1BXHZ80.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU0238689110.USD","SG9999002224.SGD","LU1093756325.SGD","LU1989772923.USD","SG9999014567.USD","SG9999014542.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","SG9999014559.SGD","IE0002141913.USD","BK4566","LU1929549753.HKD","MRK","LU2361044865.SGD","IE00BLSP4452.SGD","LU1069347547.HKD","BK4559","IE00BJJMRZ35.SGD","LU0070302665.USD","LU1057294990.SGD","BK4532","LU1116320737.USD","LU2087621335.USD","LU0889565916.HKD","LU1989771016.USD","LU0109394709.USD","LU1037948897.HKD","LU1066053197.SGD","LU1585245621.USD","LU1934455194.USD","LU0965509010.AUD","LU0106261372.USD","IE00BLSP4239.USD","IE0002270589.USD","LU2324357040.USD","IE00BJT1NW94.SGD","LU0265550946.USD","BK4588","LU0320765489.SGD","LU0985320562.USD"],"gpt_icon":0},{"id":"2529137805","title":"Gilead: Study Met Main Goal, With Statistically Significant,Clinically Meaningful Improvement in Pfs","url":"https://stock-news.laohu8.com/highlight/detail?id=2529137805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529137805?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","BK4583","IE00BSNM7G36.USD","LU0289739699.SGD","BK4550","BK4139","IE00B19Z3B42.SGD","BK4585","BK4566","LU1066051498.USD","BK4578","IE00BKVL7J92.USD","LU0234570918.USD","BK4532","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","LU0109394709.USD","LU1585245621.USD","LU1066053197.SGD","BK4568","IE00B19Z3581.USD","IE0002270589.USD","BK4588"],"gpt_icon":0},{"id":"2529051968","title":"Gilead: Will Continue to Monitor Os Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529051968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529051968?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","LU1571399168.USD","IE00BKVL7J92.USD","BK4585","LU1430594728.SGD","BK4568","LU0058720904.USD","BK4550","IE00B19Z3B42.SGD","LU1066053197.SGD","GILD","LU1066051498.USD","IE00BSNM7G36.USD","BK4532","LU0234570918.USD","LU1839511570.USD","IE00B3T34201.USD","BK4583","BK4566","LU2087621335.USD","LU1585245621.USD","IE0002270589.USD","LU0109394709.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","BK4139","LU2089984988.USD","LU2468319806.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","BK4578","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2529051698","title":"Gilead: Trodelvy Plus Keytruda Shows Early Trend in Improvement for Os VS Soc in Patients With Previously Untreated Pd-L1+ (CPS ≥10) Mtnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2529051698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529051698?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nP8N3K10U9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU1069347547.HKD","LU1989771016.USD","LU0070302665.USD","BK4534","LU0238689110.USD","IE00BFTCPJ56.SGD","IE0002270589.USD","IE00BLSP4452.SGD","LU0109394709.USD","LU1066051225.USD","LU0965509010.AUD","LU1066053197.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU2324357040.USD","BK4532","LU1934455194.USD","SG9999014559.SGD","LU0889565916.HKD","LU0320765489.SGD","LU1839511570.USD","LU1116320737.USD","LU0265550946.USD","LU1585245621.USD","IE0002141913.USD","IE00B1BXHZ80.USD","GILD","MRK","BK4559","IE00BLSP4239.USD","LU0106261372.USD","SG9999014542.SGD","LU1929549753.HKD","LU0289739699.SGD","BK4588","SG9999014567.USD","IE00BSNM7G36.USD","LU1989772923.USD","LU1037948897.HKD","LU2089984988.USD","LU2361044865.SGD","LU0985320562.USD","LU1023059063.AUD","LU2087621335.USD","LU1093756325.SGD","LU0234572021.USD","SG9999002224.SGD","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"2529805156","title":"Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated Pd-L1+ Metastatic Triple-Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529805156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529805156?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUACB5ZQM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1430594728.SGD","LU1585245621.USD","LU0889565916.HKD","LU0058720904.USD","BK4588","LU2087621335.USD","BK4532","BK4568","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","GILD","LU2089984988.USD","LU1571399168.USD","BK4585","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU1839511570.USD","IE00BKVL7J92.USD","BK4578","IE00B7SZLL34.SGD","BK4550","LU2468319806.SGD","LU0320765992.SGD","BK4139","BK4583","LU1066051498.USD"],"gpt_icon":0},{"id":"2529689806","title":"Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529689806","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529689806?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:30","pubTimestamp":1745238600,"startTime":"0","endTime":"0","summary":"– The First Pivotal Phase 3 Trial to Demonstrate Superiority of a TROP-2 Antibody-Drug Conjugate, Trodelvy, Plus Keytruda Versus Standard of Care Keytruda plus Chemotherapy in 1L mTNBC –。– Trodelvy Plus Keytruda Shows an Early Trend in Improvement for Overall Survival Versus Standard of Care in Patients with Previously Untreated PD-L1+  mTNBC –。\"These findings are the first to show the transformative potential of an antibody-drug conjugate combined with an immuno-oncology agent in early treatment lines of metastatic breast cancer,\" said Dietmar Berger, MD, PhD, Chief Medical Officer, Gilead Sciences. \"For patients with this difficult to treat type of breast cancer, these results potentially offer a new pathway that may redefine their treatment options.\". The significant and meaningful improvement in PFS demonstrated in ASCENT-04 further reinforces the potential of Trodelvy plus Keytruda as a much-needed new treatment option for patients with previously untreated inoperable  PD-L1+ loca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trodelvy-plus-keytruda-demonstrates-statistically-123000256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SAR","LU1585245621.USD","IE00BKVL7J92.USD","LU0861579265.USD","IE00BJT1NW94.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","BK4585","LU0985320562.USD","LU0109394709.USD","LU1069347547.HKD","MCBS","ADC","LU2023250843.SGD","SG9999001176.USD","LU0106261372.USD","CINV","GILD","LU1162221912.USD","SG9999014542.SGD","PFS","ORR","BK4578","LU0965508806.USD","LU1023059063.AUD","LU0203347892.USD","IE00BSNM7G36.USD","BK4203","SG9999002232.USD","BK4007","LU2106854487.HKD","LU0208291251.USD","SG9999002224.SGD","LU1035773651.USD","HR","LU0965509283.SGD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0265550359.USD","LU1066051225.USD","LU2112291526.USD","LU2361045086.USD","LU1093756325.SGD","LU0234570918.USD","PD","MRK","OS","LU0203345920.USD","LU0234572021.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2528861308","title":"Gilead Sciences: Strong Financial Outlook and Strategic Positioning Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2528861308","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528861308?lang=en_us&edition=fundamental","pubTime":"2025-04-20 22:15","pubTimestamp":1745158529,"startTime":"0","endTime":"0","summary":"In a report released on April 17, Tim Anderson from Bank of America Securities reiterated a Buy rating on Gilead Sciences (GILD – Research Report),...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-sciences-strong-financial-outlook-and-strategic-positioning-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-sciences-strong-financial-outlook-and-strategic-positioning-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD"],"gpt_icon":0},{"id":"2528003720","title":"Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528003720","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528003720?lang=en_us&edition=fundamental","pubTime":"2025-04-18 01:06","pubTimestamp":1744909560,"startTime":"0","endTime":"0","summary":"Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report first-quarter 2025 results on April 24, after market close. The Zacks Consensus Estimate for sales and earnings is pegged at $6.83 billion and $1.73 per share, respectively.Earnings estimate for 2025 has increased to $7.86 from $7.80 per share over the past 60 days, while that for 2026 has increased to $8.30 from $8.12 in the same timeframe. . GILD has an excellent track record. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 19.47%. In the previously reported quarter, the company’s earnings beat estimates by 13.77%.However, the first quarter has likely seen a slowdown due to the impact of the new Medicare Part D model implementation. As per the new model, manufacturers now must provide discounts on the cost of drug for Medicare patients during the initial coverage and catastrophic phases. Secondly, the introduction of manufacturer discounts for people who qualify for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/buy-hold-sell-gild-stock-170600539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD"],"gpt_icon":0},{"id":"2528744539","title":"Leerink Partners Adjusts Price Target on Gilead Sciences to $105 From $104, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2528744539","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528744539?lang=en_us&edition=fundamental","pubTime":"2025-04-17 22:55","pubTimestamp":1744901720,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has an average rating of overweight and mean price target of $114.24, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GILD"],"gpt_icon":0},{"id":"2528728594","title":"Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2528728594","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528728594?lang=en_us&edition=fundamental","pubTime":"2025-04-17 22:01","pubTimestamp":1744898470,"startTime":"0","endTime":"0","summary":"The market expects Gilead Sciences  to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 24. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This HIV and hepatitis C drugmaker is expected to post quarterly earnings of $1.73 per share in its upcoming report, which represents a year-over-year change ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-gild-reports-next-140110229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD"],"gpt_icon":0},{"id":"2528711090","title":"Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711090","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528711090?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:33","pubTimestamp":1744893215,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Thursday that the US Food and Drug Administration has cleared an investigational new drug application for its oral IRAK4 degrader GS-6791/NX-0479, allowing for a phase 1 trial to start, which is expected to begin in Q2.The company said it is to receive $5 million from Gilead Sciences  for the IND clearance and remains eligible for up to $420 million in potential future milestone payments as part of a 2019 collaboration agreement.Nurix said GS-6791/NX-0479 has potential applications in rheumatology and dermatology, including rheumatoid arthritis and atopic dermatitis.Under the terms of the 2019 collaboration agreement, Nurix and Gilead Sciences  are looking to discover, develop, and commercialize a pipeline of up to five therapies for cancer and other diseases, the company said.Nurix shares were over 8% higher while Gilead shares were 0.2% higher in recent premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2087621335.USD","IE00B7SZLL34.SGD","LU0058720904.USD","LU2089984988.USD","BK4139","IE00B19Z3B42.SGD","BK4550","BK4588","43A.SI","IE00BZ1G4Q59.USD","BK4578","GILD","LU0320765992.SGD","LU1585245621.USD","BK4585","BK4568","BK4583","LU0234570918.USD","LU1066053197.SGD","LU1430594728.SGD","LU1066051498.USD","IE00BKVL7J92.USD","LU0109394709.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1839511570.USD","NRIX","BK6520","BK4532","BK4566","BK6054","LU0289739699.SGD","LU1571399168.USD","IE00B19Z3581.USD","LU2468319806.SGD","LU0889565916.HKD","IE0002270589.USD"],"gpt_icon":0},{"id":"2528790993","title":"BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479","url":"https://stock-news.laohu8.com/highlight/detail?id=2528790993","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528790993?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:04","pubTimestamp":1744887869,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479 April 17 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR GS-6791/NX-0479 - A N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7XL3YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","NRIX","LU1571399168.USD","LU1066051498.USD","LU2468319806.SGD","BK4566","LU1585245621.USD","BK4532","GILD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","IE00B19Z3581.USD","BK4585","BK4583","BK4139","BK4588","IE00BKVL7J92.USD","BK4578","LU0234570918.USD","BK4568","LU2089984988.USD","LU2087621335.USD","LU0109394709.USD","IE00B3T34201.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1839511570.USD","LU1430594728.SGD","IE00BSNM7G36.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"GILD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.73,"defaultRemindTime":1745524800000,"name":null,"time":"Post Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-03-14","symbol":"GILD","amount":0.79,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-14","defaultRemindTime":1741959000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-14","currency":"USD","dateTimestamp":1741924800000,"payDate":"2025-03-28"},{"market":"US","date":"2025-02-11","symbol":"GILD","fiscalQuarterEnding":"2024/12","expectedEps":1.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":1.9},{"date":"2024-12-13","symbol":"GILD","amount":0.77,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-30"},{"market":"US","date":"2024-11-06","symbol":"GILD","fiscalQuarterEnding":"2024/09","expectedEps":1.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":2.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-12","recordDate":"2015-06-16","paymentDate":"2015-06-29","value":0.43,"currency":"USD"},{"executeDate":"2015-09-14","recordDate":"2015-09-16","paymentDate":"2015-09-29","value":0.43,"currency":"USD"},{"executeDate":"2015-12-14","recordDate":"2015-12-16","paymentDate":"2015-12-30","value":0.43,"currency":"USD"},{"executeDate":"2016-03-14","recordDate":"2016-03-16","paymentDate":"2016-03-30","value":0.43,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-29","value":0.47,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.3333,"hold":0.3667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":30,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2025-04-17","current":272.389631,"percent":0.819739,"low":-353.030459,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"high":985.638037,"avg":115.164831,"sd":257.1452,"marketCap":130747023108},"quantilePoints":[{"date":"2020-04-24","current":18.616407,"twenty":6.427197,"median":14.646819,"eighty":30.203766,"marketCap":100267968138},{"date":"2020-05-01","current":20.205018,"twenty":6.427197,"median":14.646819,"eighty":30.040279,"marketCap":100257300000},{"date":"2020-05-08","current":19.589157,"twenty":6.427197,"median":14.646819,"eighty":29.863518,"marketCap":97201394766},{"date":"2020-05-15","current":19.278218,"twenty":6.427197,"median":14.646819,"eighty":29.6922,"marketCap":95658515484},{"date":"2020-05-22","current":18.540053,"twenty":6.427197,"median":14.646819,"eighty":29.202205,"marketCap":91995745156},{"date":"2020-05-29","current":19.675107,"twenty":6.427197,"median":14.646819,"eighty":29.042662,"marketCap":97627881722},{"date":"2020-06-05","current":19.402088,"twenty":6.427197,"median":14.646819,"eighty":28.831708,"marketCap":96273158450},{"date":"2020-06-12","current":18.504662,"twenty":6.427197,"median":14.646819,"eighty":27.315326,"marketCap":91820132880},{"date":"2020-06-19","current":19.584101,"twenty":6.427197,"median":14.646819,"eighty":26.917351,"marketCap":97176307298},{"date":"2020-06-26","current":18.850992,"twenty":6.427197,"median":14.646819,"eighty":26.756696,"marketCap":93538624438},{"date":"2020-07-02","current":19.300969,"twenty":6.427197,"median":14.646819,"eighty":26.63808,"marketCap":95771409090},{"date":"2020-07-10","current":19.293385,"twenty":6.427197,"median":14.646819,"eighty":26.355806,"marketCap":95733777888},{"date":"2020-07-17","current":19.594212,"twenty":6.427197,"median":14.646819,"eighty":25.598322,"marketCap":97226482234},{"date":"2020-07-24","current":18.615892,"twenty":6.427197,"median":14.646819,"eighty":25.376857,"marketCap":92372057176},{"date":"2020-07-31","current":-339.364134,"twenty":6.410323,"median":14.629784,"eighty":25.277011,"marketCap":87216582502},{"date":"2020-08-07","current":-338.310448,"twenty":6.392142,"median":14.560725,"eighty":25.150137,"marketCap":86945785059},{"date":"2020-08-14","current":-334.163889,"twenty":6.380126,"median":14.488429,"eighty":25.150137,"marketCap":85880119345},{"date":"2020-08-21","current":-324.407279,"twenty":6.34887,"median":14.451741,"eighty":25.150137,"marketCap":83372670605},{"date":"2020-08-28","current":-318.35818,"twenty":6.326168,"median":14.415069,"eighty":25.150137,"marketCap":81818052386},{"date":"2020-09-04","current":-322.016909,"twenty":6.300695,"median":14.353547,"eighty":25.150137,"marketCap":82758345663},{"date":"2020-09-11","current":-319.919238,"twenty":6.282152,"median":14.321176,"eighty":25.150137,"marketCap":82219244184},{"date":"2020-09-18","current":-317.333736,"twenty":6.244206,"median":14.279358,"eighty":25.150137,"marketCap":81554770268},{"date":"2020-09-25","current":-303.674483,"twenty":6.163333,"median":14.261828,"eighty":25.150137,"marketCap":78044342032},{"date":"2020-10-02","current":-303.284218,"twenty":6.038611,"median":14.169569,"eighty":25.150137,"marketCap":77944044082},{"date":"2020-10-09","current":-311.430987,"twenty":5.952564,"median":14.135621,"eighty":25.150137,"marketCap":80037763780},{"date":"2020-10-16","current":-302.454906,"twenty":5.912527,"median":14.104836,"eighty":25.150137,"marketCap":77730910940},{"date":"2020-10-23","current":-296.552157,"twenty":5.894484,"median":14.057828,"eighty":25.150137,"marketCap":76213904452},{"date":"2020-10-30","current":57.495325,"twenty":5.887283,"median":14.035041,"eighty":25.277011,"marketCap":72904072115},{"date":"2020-11-06","current":58.395826,"twenty":5.887283,"median":14.035041,"eighty":25.376857,"marketCap":74045907761},{"date":"2020-11-13","current":59.893535,"twenty":5.887283,"median":14.035041,"eighty":25.598322,"marketCap":75945002907},{"date":"2020-11-20","current":59.423957,"twenty":5.887283,"median":14.035041,"eighty":26.355806,"marketCap":75349577036},{"date":"2020-11-27","current":59.34487,"twenty":5.887283,"median":14.035041,"eighty":26.598291,"marketCap":75249294784},{"date":"2020-12-04","current":60.857408,"twenty":5.887283,"median":14.035041,"eighty":26.756696,"marketCap":77167192852},{"date":"2020-12-11","current":60.066538,"twenty":5.887283,"median":14.035041,"eighty":26.917351,"marketCap":76164370333},{"date":"2020-12-18","current":58.405712,"twenty":5.887283,"median":14.035041,"eighty":27.315326,"marketCap":74058443042},{"date":"2020-12-24","current":56.418653,"twenty":5.887283,"median":14.035041,"eighty":28.776154,"marketCap":71538851463},{"date":"2020-12-31","current":57.595071,"twenty":5.887283,"median":14.035041,"eighty":28.982603,"marketCap":73030549960},{"date":"2021-01-08","current":62.320516,"twenty":5.887283,"median":14.035041,"eighty":29.131999,"marketCap":79022414512},{"date":"2021-01-15","current":62.607206,"twenty":5.887283,"median":14.035041,"eighty":29.690755,"marketCap":79385937676},{"date":"2021-01-22","current":66.176005,"twenty":5.887283,"median":14.071576,"eighty":29.782104,"marketCap":83911174294},{"date":"2021-01-29","current":64.851299,"twenty":5.887283,"median":14.109654,"eighty":29.979206,"marketCap":82231446574},{"date":"2021-02-05","current":697.695423,"twenty":5.887283,"median":14.148779,"eighty":30.122962,"marketCap":85816537080},{"date":"2021-02-12","current":681.695105,"twenty":5.887283,"median":14.235931,"eighty":30.220678,"marketCap":83848497886},{"date":"2021-02-19","current":656.013065,"twenty":5.887283,"median":14.27046,"eighty":30.484701,"marketCap":80689606951},{"date":"2021-02-26","current":627.274958,"twenty":5.887283,"median":14.306069,"eighty":30.569263,"marketCap":77154819778},{"date":"2021-03-05","current":660.171136,"twenty":5.886815,"median":14.351389,"eighty":30.669098,"marketCap":81201049740},{"date":"2021-03-12","current":628.90955,"twenty":5.886815,"median":14.411816,"eighty":30.847379,"marketCap":77355874683},{"date":"2021-03-19","current":658.536543,"twenty":5.886815,"median":14.446346,"eighty":30.947914,"marketCap":80999994835},{"date":"2021-03-26","current":666.505183,"twenty":5.887283,"median":14.479757,"eighty":31.062543,"marketCap":81980137497},{"date":"2021-04-01","current":680.094988,"twenty":5.887283,"median":14.515798,"eighty":31.220392,"marketCap":83651683496},{"date":"2021-04-09","current":666.480805,"twenty":5.886815,"median":14.621022,"eighty":31.471261,"marketCap":81977138959},{"date":"2021-04-16","current":684.496566,"twenty":5.886815,"median":14.653082,"eighty":31.596225,"marketCap":84193077595},{"date":"2021-04-23","current":670.268209,"twenty":5.886815,"median":14.712213,"eighty":42.207393,"marketCap":82442989695},{"date":"2021-04-30","current":265.489326,"twenty":5.886815,"median":14.778694,"eighty":42.567879,"marketCap":79912287049},{"date":"2021-05-07","current":277.252542,"twenty":5.886815,"median":14.856386,"eighty":42.894314,"marketCap":83453015165},{"date":"2021-05-14","current":285.544285,"twenty":5.886815,"median":14.904321,"eighty":43.205482,"marketCap":85948829715},{"date":"2021-05-21","current":286.46096,"twenty":5.886815,"median":15.044244,"eighty":43.463811,"marketCap":86224748912},{"date":"2021-05-28","current":275.460859,"twenty":5.886815,"median":15.158818,"eighty":43.913538,"marketCap":82913718554},{"date":"2021-06-04","current":280.960909,"twenty":5.886815,"median":15.193582,"eighty":44.006301,"marketCap":84569233733},{"date":"2021-06-11","current":286.544294,"twenty":5.886815,"median":15.256684,"eighty":44.397317,"marketCap":86249832475},{"date":"2021-06-18","current":277.544211,"twenty":5.886815,"median":15.331847,"eighty":44.793017,"marketCap":83540807637},{"date":"2021-06-25","current":282.835927,"twenty":5.886815,"median":15.396911,"eighty":44.953898,"marketCap":85133613908},{"date":"2021-07-02","current":288.752648,"twenty":5.886815,"median":15.472548,"eighty":45.316733,"marketCap":86914546903},{"date":"2021-07-09","current":284.252606,"twenty":5.886815,"median":15.579206,"eighty":45.697022,"marketCap":85560034484},{"date":"2021-07-16","current":285.960955,"twenty":5.886815,"median":15.726234,"eighty":45.841484,"marketCap":86074247532},{"date":"2021-07-23","current":287.58597,"twenty":5.886815,"median":15.752152,"eighty":47.568365,"marketCap":86563377017},{"date":"2021-07-30","current":16.591985,"twenty":5.886815,"median":15.856378,"eighty":51.009533,"marketCap":85647826956},{"date":"2021-08-06","current":16.706124,"twenty":5.886815,"median":15.9165,"eighty":51.009533,"marketCap":86237013283},{"date":"2021-08-13","current":17.284208,"twenty":5.886815,"median":16.177233,"eighty":51.009533,"marketCap":89221079750},{"date":"2021-08-20","current":17.59511,"twenty":5.886815,"median":16.446515,"eighty":51.009533,"marketCap":90825955833},{"date":"2021-08-27","current":17.313355,"twenty":5.886815,"median":16.628399,"eighty":51.009533,"marketCap":89371536883},{"date":"2021-09-03","current":17.478521,"twenty":5.886815,"median":16.94972,"eighty":51.009533,"marketCap":90224127302},{"date":"2021-09-10","current":17.242916,"twenty":5.886815,"median":16.972053,"eighty":51.009533,"marketCap":89007932145},{"date":"2021-09-17","current":17.393509,"twenty":5.886815,"median":17.123861,"eighty":51.009533,"marketCap":89785293998},{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108}],"updateTime":1745263107421}}}